Promises and pitfalls of immune-based strategies for Huntington's disease.

about

When nature's robots go rogue: exploring protein homeostasis dysfunction and the implications for understanding human aging disease pathologies.The adjustment of γ-aminobutyric acidA tonic subunits in Huntington's disease: from transcription to translation to synaptic levels into the neostriatum.

P2860

Q51763128-CB3CC57B-A3DB-4799-B571-0DCE0BD2B431 Q55427881-7E16F5C8-70E2-463C-8232-AA79F5781230

P2860

Promises and pitfalls of immune-based strategies for Huntington's disease.

Item

http://www.wikidata.org/entity/Q45305225

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Promises and pitfalls of immune-based strategies for Huntington's disease.

@en

Promises and pitfalls of immune-based strategies for Huntington's disease.

@nl

type

Item

label

Promises and pitfalls of immune-based strategies for Huntington's disease.

@en

Promises and pitfalls of immune-based strategies for Huntington's disease.

@nl

prefLabel

Promises and pitfalls of immune-based strategies for Huntington's disease.

@en

Promises and pitfalls of immune-based strategies for Huntington's disease.

@nl

P1476

Promises and pitfalls of immune-based strategies for Huntington's disease.

@en

P2093

Antonio Lucio Teixeira

http://www.w3.org/2001/XMLSchema#string

Erin Furr Stimming

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology

Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges

Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders

Huntington's disease: underlying molecular mechanisms and emerging concepts

Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease.

Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies

Laquinimod therapy in multiple sclerosis: a comprehensive review

Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice

Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats

Microglia: a sensor for pathological events in the CNS

P304

1422-1425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1673-5374.215245

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Natalia Pessoa Rocha

Gabriela D Colpo

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29089980

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

5649455

http://www.w3.org/2001/XMLSchema#string

Promises and pitfalls of immune-based strategies for Huntington's disease.

about

P2860

P2860

Promises and pitfalls of immune-based strategies for Huntington's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932